Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Assessment of T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%) Versus Rhopressa® Ophthalmic Solution (Preserved Netarsudil 0.02%) in Patients With Open-angle Glaucoma or Ocular Hypertension

NCT06394973 is registered in ClinicalTrials.gov with Laboratoires Thea as lead sponsor.

NCT NCT06394973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06394973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Assessment of T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%) Versus Rhopressa® Ophthalmic Solution (Preserved Netarsudil 0.02%) in Patients With Open-angle Glaucoma or Ocular Hypertension
Lead sponsor
Laboratoires Thea
Phase
Phase 2
Overall status
Completed
Start date
August 5, 2024
Completion date
November 21, 2024
Enrollment
161 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, ocular hypertension